ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Data collection Completed In NCI Study of BRACA1

August 16, 1996

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996

Two New Communications Contracts Approved

October 18, 1985

Surgery, Radiation Effective For Older Women, Study Finds

September 24, 2004

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012